We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$4.78B
AUM Growth
+$300M
Cap. Flow
-$1.75M
Cap. Flow %
-0.04%
Top 10 Hldgs %
35.41%
Holding
646
New
42
Increased
82
Reduced
148
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 22.82%
2 Healthcare 17.92%
3 Consumer Staples 12.87%
4 Consumer Discretionary 9.99%
5 Industrials 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
1
Mastercard
MA
$493B
$247M 5.16%
2,194,085
-9,591
-0.4% -$1.05M
TJX icon
2
TJX Companies
TJX
$178B
$205M 4.28%
5,174,168
-56,454
-1% -$2.18M
FISV
3
Fiserv Inc
FISV
$27.9B
$180M 3.76%
3,124,366
-35,086
-1% -$1.97M
SYK icon
4
Stryker
SYK
$130B
$175M 3.65%
1,327,539
-6,901
-0.5% -$872K
AMT icon
5
American Tower
AMT
$80.4B
$166M 3.46%
1,361,727
+73,973
+6% +$8.14M
ADP icon
6
Automatic Data Processing
ADP
$108B
$156M 3.27%
1,526,880
+899
+0.1% +$91.7K
CNI icon
7
Canadian National Railway
CNI
$76.6B
$156M 3.25%
2,106,477
-25,257
-1% -$1.79M
INTU icon
8
Intuit
INTU
$89B
$144M 3.01%
1,242,355
-22,265
-2% -$2.67M
DHR icon
9
Danaher
DHR
$144B
$142M 2.97%
1,874,981
+47,112
+3% +$3.51M
CHD icon
10
Church & Dwight Co
CHD
$24.5B
$124M 2.59%
2,485,493
-16,154
-0.6% -$772K
CELG
11
DELISTED
Celgene Corp
CELG
$117M 2.46%
944,073
+49,400
+6% +$5.91M
CL icon
12
Colgate-Palmolive
CL
$74.4B
$115M 2.4%
1,566,993
+2,097
+0.1% +$147K
EOG icon
13
EOG Resources
EOG
$70.7B
$107M 2.24%
1,096,519
+36,125
+3% +$3.6M
CTSH icon
14
Cognizant
CTSH
$26B
$105M 2.19%
1,760,990
-8,304
-0.5% -$477K
SBUX icon
15
Starbucks
SBUX
$120B
$104M 2.17%
1,778,854
+9,024
+0.5% +$511K
MSFT icon
16
Microsoft
MSFT
$3.71T
$98.8M 2.06%
1,499,604
+41,871
+3% +$2.68M
UL icon
17
Unilever
UL
$136B
$97.4M 2.04%
1,755,464
+12,828
+0.7% +$649K
ABT icon
18
Abbott
ABT
$187B
$94.5M 1.97%
2,127,244
+40,103
+2% +$1.73M
GOOGL icon
19
Alphabet (Google) Class A
GOOGL
$4.33T
$90.7M 1.9%
2,140,540
+248,220
+13% +$10.4M
RTX icon
20
RTX Corp
RTX
$301B
$84M 1.76%
1,190,213
-35,554
-3% -$2.49M
XOM icon
21
ExxonMobil
XOM
$634B
$82M 1.71%
999,961
-25,136
-2% -$2.1M
AAPL icon
22
Apple
AAPL
$4.57T
$79M 1.65%
2,200,840
-32,356
-1% -$1.07M
WEX icon
23
WEX
WEX
$6.31B
$77.2M 1.61%
746,363
+6,902
+0.9% +$766K
JNJ icon
24
Johnson & Johnson
JNJ
$625B
$74.8M 1.56%
600,774
-1,895
-0.3% -$226K
PG icon
25
Procter & Gamble
PG
$339B
$71.8M 1.5%
798,556
-8,403
-1% -$745K

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Loring Wolcott & Coolidge Fiduciary Advisors held 646 positions worth $4.78B, up 6.7% from $4.49B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2017 filing shows 42 new, 82 increased, 148 reduced and 23 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 4,241 shares worth $231K. The largest sale was Praxair Inc, an estimated $44.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 4,241 shares worth $231K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Occidental Petroleum in Q1 2017, an estimated $17.1M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2017 reduction was Praxair Inc, cutting an estimated $44.3M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Linear Technology Corp in Q1 2017, selling an estimated $6.42M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 35% of its $4.78B portfolio in Q1 2017.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 42 new positions and closed 23 in Q1 2017.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 6.7% quarter-over-quarter to $4.78B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2017, filed 15 May 2017.